Haleon (NYSE:HLN – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.13), FiscalAI reports. The business had revenue of $3.71 billion during the quarter, compared to analysts’ expectations of $7.43 billion.
Haleon Stock Down 1.7%
HLN stock traded down $0.17 during trading on Thursday, reaching $10.11. 16,090,150 shares of the stock were exchanged, compared to its average volume of 9,834,686. The firm’s 50 day moving average is $9.43 and its 200 day moving average is $9.85. The firm has a market cap of $44.51 billion, a P/E ratio of 25.91, a price-to-earnings-growth ratio of 2.38 and a beta of 0.13. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 0.47. Haleon has a twelve month low of $8.65 and a twelve month high of $11.28.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on HLN shares. Rothschild & Co Redburn lowered Haleon from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Zacks Research cut Haleon from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Haleon in a research report on Thursday, April 30th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research note on Tuesday, June 30th. Finally, Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a research note on Sunday, July 12th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy”.
Institutional Investors Weigh In On Haleon
Hedge funds and other institutional investors have recently modified their holdings of the company. Parkside Financial Bank & Trust raised its position in shares of Haleon by 101.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock worth $29,000 after purchasing an additional 1,433 shares during the period. Geneos Wealth Management Inc. increased its stake in Haleon by 33.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock valued at $50,000 after purchasing an additional 1,203 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its stake in Haleon by 428.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 6,321 shares of the company’s stock valued at $57,000 after purchasing an additional 5,124 shares in the last quarter. Cary Street Partners Financial LLC raised its holdings in Haleon by 20.1% during the second quarter. Cary Street Partners Financial LLC now owns 6,646 shares of the company’s stock worth $69,000 after buying an additional 1,113 shares during the last quarter. Finally, McMillan Office Inc. acquired a new position in Haleon during the fourth quarter worth $92,000. Institutional investors own 6.67% of the company’s stock.
About Haleon
Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.
The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.
Featured Stories
- Five stocks we like better than Haleon
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
